MLKL and skin disorder: Interestingly, while RIP3 loss delays the development of dermatitis in SHARPIN deficient mice (Kumari et al., 2014; Rickard et al., 2014), MLKL loss does not affect the development of dermatitis (Rickard et al., 2014).